Eric Boitier

1.9k total citations
38 papers, 1.4k citations indexed

About

Eric Boitier is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Eric Boitier has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Pharmacology. Recurrent topics in Eric Boitier's work include Mitochondrial Function and Pathology (5 papers), Molecular Biology Techniques and Applications (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Eric Boitier is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Molecular Biology Techniques and Applications (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Eric Boitier collaborates with scholars based in France, United States and Germany. Eric Boitier's co-authors include Michael R. Duchen, Ruth Rea, Jean‐Charles Gautier, Ruth Roberts, C. Marsac, Philippe Beaune, Michael T. Murray, Jorge H. Capdevila, Irina A. Pikuleva and Ronald W. Estabrook and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Eric Boitier

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Boitier France	21	878	260	181	150	135	38	1.4k
Shripad V. Bhagwat United States	20	868 1.0×	276 1.1×	301 1.7×	570 3.8×	179 1.3×	46	1.5k
Sudhir Chowdhry United Kingdom	14	2.4k 2.7×	305 1.2×	99 0.5×	159 1.1×	106 0.8×	16	3.1k
John Skoko United States	20	1.3k 1.4×	149 0.6×	101 0.6×	232 1.5×	58 0.4×	30	1.8k
Renee Risingsong United States	26	2.0k 2.3×	354 1.4×	135 0.7×	356 2.4×	81 0.6×	30	2.5k
William K. Chan United States	15	718 0.8×	319 1.2×	180 1.0×	217 1.4×	58 0.4×	37	1.4k
Yangsik Jeong South Korea	18	853 1.0×	265 1.0×	72 0.4×	315 2.1×	165 1.2×	29	1.6k
M. Sambasiva Rao United States	18	685 0.8×	206 0.8×	105 0.6×	378 2.5×	55 0.4×	33	1.6k
Kozue Takeda Japan	21	714 0.8×	93 0.4×	82 0.5×	201 1.3×	46 0.3×	34	1.6k
Chi‐Wai Wong China	25	1.1k 1.3×	324 1.2×	75 0.4×	195 1.3×	80 0.6×	49	1.9k
Jiahong Sun China	23	658 0.7×	189 0.7×	192 1.1×	129 0.9×	53 0.4×	55	1.4k

Countries citing papers authored by Eric Boitier

Since Specialization

Citations

This map shows the geographic impact of Eric Boitier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Boitier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Boitier more than expected).

Fields of papers citing papers by Eric Boitier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Boitier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Boitier. The network helps show where Eric Boitier may publish in the future.

Co-authorship network of co-authors of Eric Boitier

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Boitier. A scholar is included among the top collaborators of Eric Boitier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Boitier. Eric Boitier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gazzah, Anas, Nils Ternès, Joon Sang Lee, et al.. (2025). Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancer. Translational Oncology. 63. 102615–102615.

Tolaney, Sara M., Arlene Chan, Katarína Petráková, et al.. (2023). AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer. Journal of Clinical Oncology. 41(24). 4014–4024. 37 indexed citations

Chandarlapaty, Sarat, Aditya Bardia, Simon Lord, et al.. (2020). 277MO SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study. Annals of Oncology. 31. S351–S351. 3 indexed citations

Wolfinger, Russell D., Sudheer Beedanagari, Eric Boitier, et al.. (2018). Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR. BMC Biotechnology. 18(1). 6–6. 20 indexed citations

Agueusop, Inoncent, Stéphane Illiano, Corinne Rocher, et al.. (2017). OP0339 Identification of a transcriptomic signature correlated with modified rodnan skin score (MRSS) in patients with diffuse cutaneous systemic sclerosis. Annals of the Rheumatic Diseases. 76. 195–196. 1 indexed citations

Veeranagouda, Yaligara, Jean‐François Léonard, Jean‐Charles Gautier, & Eric Boitier. (2017). Next-Generation Sequencing to Investigate Urinary microRNAs from Macaca fascicularis (Cynomolgus Monkey). Methods in molecular biology. 1641. 349–378. 1 indexed citations

Gautier, Jean‐Charles, Xiaobing Zhou, Yi Yang, et al.. (2016). Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin. Toxicology and Applied Pharmacology. 303. 1–10. 31 indexed citations

Veeranagouda, Yaligara, Catherine Prades, Jean‐François Léonard, et al.. (2015). Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex Tissues. PLoS ONE. 10(11). e0142708–e0142708. 16 indexed citations

Boitier, Eric, Alexander Amberg, Valérie Barbié, et al.. (2011). A comparative integrated transcript analysis and functional characterization of differential mechanisms for induction of liver hypertrophy in the rat. Toxicology and Applied Pharmacology. 252(2). 85–96. 8 indexed citations

10.

Com, Emmanuelle, Eric Boitier, Arnd Brandenburg, et al.. (2011). Integrated transcriptomic and proteomic evaluation of gentamicin nephrotoxicity in rats. Toxicology and Applied Pharmacology. 258(1). 124–133. 24 indexed citations

11.

Fielden, Mark R., Alex Adai, Robert T. Dunn, et al.. (2011). Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat. Toxicological Sciences. 124(1). 54–74. 41 indexed citations

12.

Michel, Cécile, Chantal Desdouets, Mohamed Slaoui, et al.. (2007). Diethylnitrosamine Initiation Does Not Alter Clofibric Acid–Induced Hepatocarcinogenesis in the Rat. Toxicological Sciences. 99(1). 58–69. 4 indexed citations

13.

Boitier, Eric, et al.. (2007). Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 619(1-2). 16–29. 35 indexed citations

14.

Thybaud, Véronique, et al.. (2007). Application of toxicogenomics to genetic toxicology risk assessment. Environmental and Molecular Mutagenesis. 48(5). 369–379. 15 indexed citations

15.

Léonard, Jean‐François, Eric Boitier, Marc Duchesne, et al.. (2006). Proteomic characterization of the effects of clofibrate on protein expression in rat liver. PROTEOMICS. 6(6). 1915–1933. 27 indexed citations

16.

Boitier, Eric, Ting Hu, Gregory J. Carr, et al.. (2005). Laboratory variability does not preclude identification of biological functions impacted by hydroxyurea. Environmental and Molecular Mutagenesis. 46(4). 221–235. 8 indexed citations

17.

Marchand, Alexandre, et al.. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Insulin-Like Growth Factor Binding Protein-1 Gene Expression and Counteracts the Negative Effect of Insulin. Molecular Pharmacology. 67(2). 444–452. 45 indexed citations

18.

Michel, Cécile, et al.. (2003). Liver Gene Expression Profiles of Rats Treated with Clofibric Acid. American Journal Of Pathology. 163(6). 2191–2199. 29 indexed citations

19.

Boitier, Eric & Philippe Beaune. (2000). Xenobiotic-Metabolizing Enzymes as Autoantigens in Human Autoimmune Disorders : An Update. Clinical Reviews in Allergy & Immunology. 18(2). 215–240. 10 indexed citations

20.

Degoul, Françoise, Monique Diry, Fausto Viader, et al.. (1995). Intrafamilial heterogeneous clinical presentation of the mitochondrial 3243 MELAS mutation; molecular investigations among four generations. European Journal of Neurology. 2(6). 573–579. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact